Ajanta Pharma Ltd. Financials

NSE BSE

15:59 Jul 18

Ajanta Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

2772.80

-13.60 (-0.49%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

2772.80

-13.60 (-0.49%)
15:59 Jul 18

Quality

77/100
High Financial Strength

Valuation

35/100
Mid Valuation

Technical

53/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Sales	2889.69	3340.99	3742.64	4208.71	4648.1
Operating Expenses +	1891.13	2411.69	2959.39	3036.77	3388.6
Raw Material	795.95	915.44	1024.64	1105.78	1096.4
Increase Decrease in Cost	-150.9	-83.17	25.76	-39.21	-25.64
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	548.25	645.78	785.14	900.34	1089.69
Miscellaneous Expenses	876.91	1205.84	1416.41	1402.56	1727.75
Operating Profit	998.56	929.3	783.25	1171.94	1259.5
Other Income	25.98	115.68	98.64	84.6	94.5
Depreciation	116.09	125.3	130.8	135.4	144.11
Interest	8.27	10.2	5.84	7.21	20.73
Profit before tax and exceptio..	900.18	909.48	745.25	1113.93	1189.16
Exceptional Items	0	0	0	0	0
PBT	900.18	909.48	745.25	1113.93	1189.16
Provision for Taxation	246.31	196.8	157.27	297.76	268.77
Net Profit	653.87	712.68	587.98	816.17	920.39
NET Profit after MI	653.87	712.68	587.98	816.17	920.39
EPS	75.09	82.45	45.89	64.82	73.53
Operating Profit Margin (%)	34.56	27.82	20.93	27.85	27.1
Net Profit Margin (%)	22.63	21.33	15.71	19.39	19.8

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	66.30	66.30	66.30	66.30	66.30
FII	8.90	8.90	9.30	9.10	8.40
MF	14.70	15.10	14.90	14.90	14.80
Others	2.70	2.30	2.10	2.20	2.60

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: